PARTICIPATION OF ENDOGENOUS TUMOR-NECROSIS-FACTOR-ALPHA IN HOST-RESISTANCE TO CYTOMEGALOVIRUS-INFECTION

被引:95
作者
PAVIC, I
POLIC, B
CRNKOVIC, I
LUCIN, P
JONJIC, S
KOSZINOWSKI, UH
机构
[1] UNIV ULM, INST MICROBIOL, DEPT VIROL, W-7900 ULM, GERMANY
[2] UNIV RIJEKA, FAC MED, DEPT PHYSIOL & IMMUNOL, 51000 RIJEKA, CROATIA
关键词
D O I
10.1099/0022-1317-74-10-2215
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Interferon gamma (IFNgamma) represents an essential cytokine involved in murine cytomegalovirus (MCMV) clearance from the salivary gland and the control of horizontal transmission. Because IFNgamma cannot be responsible for all cytokine effects during recovery from MCMV infection we have now tested the potential participation of tumour necrosis factor alpha (TNFalpha) in the antiviral defence. Neutralization of endogenous TNFalpha abolished the antiviral activity of CD4 T cells in immunocompetent as well as in CD8 subset-deficient mice. These data suggest that the antiviral effect of the CD4 subset requires the presence of at least two cytokines, namely IFNgamma and TNFalpha. Depletion of endogenous TNFalpha in adoptive cell transfer recipients diminished the antiviral function of CD8 T lymphocytes suggesting that TNFalpha also participates in CD8 T cell effector functions. Furthermore. endogenous cytokines were found to be required for survival after infection with lethal doses of MCMV, whereas immunotherapy with recombinant TNFalpha. and IFNgamma could not limit virus replication in vivo. The results suggest that, similar to IFNgamma, TNFalpha is an integral part of the protective mechanisms involved in cytomegalovirus clearance.
引用
收藏
页码:2215 / 2223
页数:9
相关论文
共 48 条
[1]   TUMOR NECROSIS FACTORS ALPHA AND BETA IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) AND AIDS-RELATED COMPLEX [J].
AMMANN, AJ ;
PALLADINO, MA ;
VOLBERDING, P ;
ABRAMS, D ;
MARTIN, NL ;
CONANT, M .
JOURNAL OF CLINICAL IMMUNOLOGY, 1987, 7 (06) :481-485
[2]  
ASHER AL, 1991, J IMMUNOL, V146, P3227
[3]   ADOPTIVE TRANSFER STUDIES DEMONSTRATING THE ANTIVIRAL EFFECT OF NATURAL-KILLER CELLS INVIVO [J].
BUKOWSKI, JF ;
WARNER, JF ;
DENNERT, G ;
WELSH, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (01) :40-52
[4]   IMPORTANCE OF ENDOGENOUS TUMOR-NECROSIS-FACTOR-ALPHA AND GAMMA-INTERFERON IN HOST-RESISTANCE AGAINST PNEUMOCYSTIS-CARINII INFECTION [J].
CHEN, WX ;
HAVELL, EA ;
HARMSEN, AG .
INFECTION AND IMMUNITY, 1992, 60 (04) :1279-1284
[5]   THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO [J].
COBBOLD, SP ;
JAYASURIYA, A ;
NASH, A ;
PROSPERO, TD ;
WALDMANN, H .
NATURE, 1984, 312 (5994) :548-551
[6]   PRESENTATION OF CMV IMMEDIATE-EARLY ANTIGEN TO CYTOLYTIC LYMPHOCYTE-T IS SELECTIVELY PREVENTED BY VIRAL GENES EXPRESSED IN THE EARLY PHASE [J].
DELVAL, M ;
MUNCH, K ;
REDDEHASE, MJ ;
KOSZINOWSKI, UH .
CELL, 1989, 58 (02) :305-315
[7]   PROTECTION AGAINST LETHAL CYTOMEGALOVIRUS-INFECTION BY A RECOMBINANT VACCINE CONTAINING A SINGLE NONAMERIC T-CELL EPITOPE [J].
DELVAL, M ;
SCHLICHT, HJ ;
VOLKMER, H ;
MESSERLE, M ;
REDDEHASE, MJ ;
KOSZINOWSKI, UH .
JOURNAL OF VIROLOGY, 1991, 65 (07) :3641-3646
[8]   EFFICIENT PROCESSING OF AN ANTIGENIC SEQUENCE FOR PRESENTATION BY MHC CLASS-I MOLECULES DEPENDS ON ITS NEIGHBORING RESIDUES IN THE PROTEIN [J].
DELVAL, M ;
SCHLICHT, HJ ;
RUPPERT, T ;
REDDEHASE, MJ ;
KOSZINOWSKI, UH .
CELL, 1991, 66 (06) :1145-1153
[9]  
DOHERTY PC, 1992, ANNU REV IMMUNOL, V10, P123
[10]   CYTOMEGALO-VIRUS INFECTION IN PATIENTS WITH AIDS [J].
DREW, WL .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (02) :449-456